Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYOZ3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TAGLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEGF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIF19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBEAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOX10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR2L1P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRINP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OBP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C17orf59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAS2L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT33A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRPC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIRREL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BDKRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on